Cargando…

AIF-1, a potential biomarker of aggressive tumor behavior in patients with non-small cell lung cancer

Allogeneic inflammatory factor-1 (AIF-1) overexpression has been reported to be associated with tumorigenesis and tumor metastasis. This study aimed to investigate the role of AIF-1 in the development and progression of non-small cell lung cancer (NSCLC). AIF-1, IL-6, and VEGF expressions in human N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lingling, Zhao, Xing, Zheng, Huachuan, Zhu, Cuimin, Liu, Yanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754194/ https://www.ncbi.nlm.nih.gov/pubmed/36520870 http://dx.doi.org/10.1371/journal.pone.0279211

Ejemplares similares

AIF-regulated oxidative phosphorylation supports lung cancer development
por: Rao, Shuan, et al.
Publicado: (2019)

AIF inhibits tumor metastasis by protecting PTEN from oxidation
por: Shen, Shao-Ming, et al.
Publicado: (2015)

An AIF orthologue regulates apoptosis in yeast
por: Wissing, Silke, et al.
Publicado: (2004)

Prognostic Value of Apoptosis-Inducing Factor (AIF) in Germ Cell Tumors
por: Letkovska, Katarina, et al.
Publicado: (2021)

A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer
por: He, Xin, et al.
Publicado: (2022)

IMMU-29. AIF1 IS A PROGNOSTIC BIOMARKER AND CORRELATED WITH IMMUNE INFILTRATES IN GLIOMAS
por: Chai, Yi, et al.
Publicado: (2020)

An isoform of AIF1 involved in breast cancer
por: Slim, Ferial Amira, et al.
Publicado: (2018)

AIF3 splicing switch triggers neurodegeneration
por: Liu, Shuiqiao, et al.
Publicado: (2021)

AIF1: Function and Connection with Inflammatory Diseases
por: De Leon-Oliva, Diego, et al.
Publicado: (2023)

Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis
por: Zhao, Ruhan, et al.
Publicado: (2022)

Biomarkers of immunotherapy in non-small cell lung cancer
por: Wang, Lingling, et al.
Publicado: (2020)

Amelogenin is a Potential Biomarker for the Aggressiveness in Odontogenic Tumors
por: Zakaraia, Safa, et al.
Publicado: (2018)

AIF examen retrospectivo : los primeros veinte años de la Asociación Internacional de Fomento.
Publicado: (1982)

Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
por: Guijarro, Luis G., et al.
Publicado: (2022)

Role of apoptosis-inducing factor (Aif) in the T cell lineage
por: Prabhu, Savit B., et al.
Publicado: (2013)

Role of aIF1 in Pyrococcus abyssi translation initiation
por: Monestier, Auriane, et al.
Publicado: (2018)

Structural and biochemical insights of CypA and AIF interaction
por: Farina, Biancamaria, et al.
Publicado: (2017)

Role of aIF5B in archaeal translation initiation
por: Kazan, Ramy, et al.
Publicado: (2022)

Differentiation-related genes in tumor-associated macrophages as potential prognostic biomarkers in non-small cell lung cancer
por: Li, Zhaoxun, et al.
Publicado: (2023)

Expression of Allograft Inflammatory Factor-1 (AIF-1) in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2018)

A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer
por: Ding, Cuimin, et al.
Publicado: (2013)

Decreased complement 4d increases poor prognosis in patients with non-small cell lung cancer combined with gastrointestinal lymph node metastasis
por: Wang, Yan, et al.
Publicado: (2022)

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
por: Shen, Jun, et al.
Publicado: (2011)

Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma
por: Deng, Boya, et al.
Publicado: (2013)

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer
por: Cai, Jun, et al.
Publicado: (2022)

AIF Downregulation and Its Interaction with STK3 in Renal Cell Carcinoma
por: Xu, Shengqiang, et al.
Publicado: (2014)

Modification of translation factor aIF5A from Sulfolobus solfataricus
por: Bassani, F., et al.
Publicado: (2018)

Identification of Novel Interaction Partners of AIF Protein on the Outer Mitochondrial Membrane
por: Fadeeva, N. P., et al.
Publicado: (2018)

Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency
por: Bénit, Paule, et al.
Publicado: (2017)

AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration
por: Jang, Ki-Hong, et al.
Publicado: (2017)

Heat Shock Protein 70 Prevents Hyperoxia-Induced Disruption of Lung Endothelial Barrier via Caspase-Dependent and AIF-Dependent Pathways
por: Kondrikov, Dmitry, et al.
Publicado: (2015)

RSPH14 regulates the proliferation, cell cycle progression, and apoptosis of non‐small cell lung cancer cells
por: Ma, Ke, et al.
Publicado: (2021)

El Banco Mundial, la AIF y la CFI : normas y operaciones.
Publicado: (1969)

AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma
por: Kwon, Jung-Hee, et al.
Publicado: (2015)

5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer
por: Zhang, Ji, et al.
Publicado: (2018)

Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer
por: Leiser, Dominic, et al.
Publicado: (2021)

Identification of key candidate tumor biomarkers in non-small-cell lung cancer by in silico analysis
por: Chen, Weiping, et al.
Publicado: (2020)

Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer
por: Wu, Shanshan, et al.
Publicado: (2016)

Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner
por: Guo, J-Y, et al.
Publicado: (2017)

miR-802 inhibits the aggressive behaviors of non-small cell lung cancer cells by directly targeting FGFR1
por: Zhang, Jiexia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3lgcgoragcj6t38odgcaikrnku